Our life sciences team is consistently regarded as the leading choice for developing and implementing IP strategy by some of Australasia’s most innovative universities, start-ups, and research organisations.
James & Wells has an experienced team of life science specialists, with proven research experience across a range of life sciences including immunology, gene therapy, synthetic medicinal chemistry, drug development and repurposing, antibodies, cell therapies, cell biology, microbiology, vaccines and diagnostics.
Through defending the patent rights of our clients before the courts and patent offices of both Australia and New Zealand we are uniquely placed to advise innovators on established strategies for success. In the ever-evolving life sciences sector, our team also have the experience, expertise and confidence to carve out effective new strategies for overcoming complex hurdles in newly developing areas.
In order to keep abreast of industry trends and be at the forefront of life sciences innovation, James & Wells is an active member of AusBiotech, Life Sciences Queensland, Biotech New Zealand and Natural Health Products NZ. We understand the life sciences industry of today, and where it will be, tomorrow.
Our Head of Biotechnology, Dr Andrew Clarke sits on the AusBiotech Intellectual Property Expert Panel, which regularly provides expertise to government departments on intellectual property issues, advocating for the Australian biotechnology sector.
In addition, Andrew is on the biotechnology standing committee of The International Association for the Protection of Intellectual Property (AIPPI), regularly being involved in significant consultations on global intellectual property issues that impact the biotechnology industry.
